Particle accelerator firm IBA's H1 revenue up 6% on equipment order intake growth
Particle accelerator firm IBA's H1 revenue up 6% on equipment order intake growth
Overview
Belgium particle accelerator firm's H1 revenue rose 6% yr/yr to €323.7 mln
Company posted net profit of €9.3 mln, reversing a loss in H1 2025
Full-year adjusted EBIT guidance of at least €32 mln reiterated
Outlook
IBA reiterates FY2026 adjusted EBIT guidance of at least €32 mln
Company expects net financial position to improve over 2027
Result Drivers
PROTON THERAPY PROFITABILITY - Co said improved execution and growing service activity in Proton Therapy drove higher profitability
EQUIPMENT ORDER INTAKE - Strong growth in equipment order intake, led by IBA Clinical, contributed to commercial momentum
GROSS MARGIN IMPROVEMENT - Higher gross margin was driven by equipment profitability mix and improved execution in Proton Therapy
Company press release: ID:nGNE3Bpysf
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Sales |
| EUR 323.70 mln |
|
H1 Net Income |
| EUR 9.30 mln |
|
H1 Gross Margin |
| 33.70% |
|
H1 Pretax Profit |
| EUR 12.30 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Ion Beam Applications SA is €18.00, about 11.4% above its August 26 closing price of €16.16
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
Aug 26 - Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Aug 26 - Belgium's DEME H1 net profit rises 20%
Aug 26 - Agilent raises annual profit forecast on improving lab tools demand
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ion Beam Applications SA
See all newsBrief: IBA Signs Contract With Government Of Assam For India's State-Run Proton Therapy Center
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS